Laurus Labs (LAURUSLABS.NS) Financial Analysis & Valuation | Quarter Chart

Laurus Labs (LAURUSLABS.NS)

LAURUSLABS.NS
Price: $16.03
Fair Value: 🔒
🔒score
Laurus Labs Limited, together with its subsidiaries, engages in the development, manufacture, and sale of medicines and active pharmaceutical ingredients (APIs) in India and internationally. The company develops, manufactures, and sells APIs and advanced intermediates for anti-retroviral (ARV), anti... more
Laurus Labs Limited, together with its subsidiaries, engages in the development, manufacture, and sa... more
Description Shares
Market Cap$8.65BExchangeNSE
SectorHealthcareIndustryDrug Manufacturers - Specialty & Generic
CountryINCEOSatyanarayana Chava
IPO Date2016-12-19CAGR0.19%
Employees6,007Websitewww.lauruslabs.com
Div. Yield0.12%Payout Ratio0.05%
Buy Back Yield—Total Yield0.12%
LAURUSLABS.NS chart loading...
Fundamentals Technicals
Enterprise Value$560.90BP/E Ratio92.22
Forward P/E60.44PEG Ratio4.55
P/S Ratio13.44P/B Ratio17.29
P/CF Ratio83.8P/FCF Ratio151.58
EPS$0.17EPS Growth 1Y147.74%
EPS Growth 3Y12.36%EPS Growth 5Y-10.01%
Revenue Growth 1Y22.67%Gross Margin0.45%
Operating Margin0.26%Profit Margin0.13%
ROE0.19%ROA0.08%
ROCE0.25%Current Ratio1.33
Quick Ratio0.68Cash Ratio0.03
Debt/Equity0.48Interest Coverage10.25
Altman Z Score9.78Piotroski Score6

View Laurus Labs financial charts →